Search Results

Retrospective Analysis of Real-World Data Presented as Late-Breaker at 29th Annual International AF Symposium

Kamili Organisation is working to make mental healthcare available at the primary care level by providing scholarships for mental health training, and driving a community-focused destigmatization campaign.

The company makes the list for the 22nd year in a row, thanks to its dedication to innovation, social responsibility and more.

Data supporting the application showed the addition of DARZALEX FASPRO® to lenalidomide, bortezomib and dexamethasone (VRd) induction and consolidation and lenalidomide maintenance therapy reduced the risk of progression or death by 58 percent compared to standard of care If approved, the DARZALEX FASPRO®-based regimen has the potential to provide an effective quadruplet therapy for many patients with newly diagnosed multiple myeloma who are eligible for transplant

Clinical and real-world evidence data support treatment with ERLEADA® (apalutamide) and niraparib plus abiraterone acetate given with prednisone in patients with prostate cancer Additional updates will be presented on innovative targeted releasing systems TAR-200 and TAR-210 in bladder cancer

Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2023.